Search This Blog

Friday, June 5, 2020

Pliant Therapeutics closes $166M IPO

Pliant Therapeutics (NASDAQ:PLRX) has closed its IPO of 10.35M common shares at $16 per share yielding gross proceeds of ~$165.6M.
The offering included underwriters’ full exercise of their over-allotment of 1.35M shares.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.